Update: Amarin Corporation plc (AMRN)
Update: Amarin Corporation plc (AMRN)
To all blog readers: Usually I do not post something that's not part of my blog portfolio. However, we had some discussions going on regarding AMRN in my WhatsApp investment group. Hence, I thought of providing an update. It's just not because I won the stock but it seems to be breakthrough for the patients with cardiovascular problem.
The results published shows these outstanding results:
Cardiovascular Death Reduced by 20%
Fatal or Nonfatal Heart Attacks Reduced by 31%
Fatal or Nonfatal Stroke Reduced by 28%
Urgent or Emergent Coronary Revascularization Reduced by 35%
Hospitalization for Unstable Angina Reduced by 32%
Dr. Bhatt stated, “REDUCE-IT establishes a new paradigm for the prevention of important cardiovascular events in statin-treated patients at elevated risk with increased triglycerides. I believe that the results of this study may represent the most significant breakthrough in preventative cardiovascular care since the introduction of statin therapy decades ago.”
I do not know where the stock price will go on Monday, once the stock market opens. But possibly higher or much higher. Also, it could be a significant acquisition target. In worst case scenario, if it comes down then it may be a great opportunity to accumulate.
Disclaimer: This is just an update for the reader, NOT a recommendation to buy or sell. I have simply expressed my view. Each investor must decide what's best for them.
Comments
Post a Comment